arrow
A

Aurélien Dupré

department of surgical oncology
H指数:24
被引数:2,464

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: Enhanced Recovery After Liver Surgery: Does Compliance Impact Survival?

ASO视觉摘要:肝切除术后加速康复:依从性是否影响生存?

2026-04-190
PRE
Hepatobiliary Surgical Training in a Changing Educational Landscape: An 18-Year Longitudinal Analysis of a High-Volume International Fellowship Programme

肝胆外科培训在变化的教育环境中的18年纵向分析:一项高容量国际培训项目的评估

2026-04-090
PRE
Enhanced Recovery After Liver Surgery: Does Compliance Impact Survival?

肝切除术后快速康复:依从性是否影响生存?

2026-04-020
OAAI
Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES)

新辅助帕博利珠单抗联合观察等待策略治疗局部MSI/dMMR结直肠癌:一项随机GERCOR 109 – PRODIGE 84期II临床试验(PREMICES)的研究方案

2025-11-220
OAAI
ASO Author Reflections: Complete Pathological Response after Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinomas-Curative Surgery in Cured Patients?
2025-02-010
PRE
ASO Visual Abstract: Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for Pancreatic AdenOcarciNOma in the FOFLIRINOX Era: The Multicenter TONO Study
2025-01-290
PRE
Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma in the FOFLIRINOX Era: the Multicenter TONO Study

Fofirinox时代胰腺腺癌新辅助治疗后完全病理缓解的预后: 多中心TONO研究

2025-01-081
PRE
Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR)
2024-09-011
OAAI
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study

三联化疗加或不加贝伐单抗作为转移性结直肠癌的一线治疗: 一项AGEO多中心真实世界研究

2024-09-010
PRE
Hepatectomy v°ersus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study
2024-07-250
PRE
Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?
SURGERY
IF2.7
2024-07-017
PRE
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study

化疗或免疫检查点抑制剂治疗MMR缺陷转移性结直肠癌后的完全病理缓解: 一项回顾性多中心研究的结果

2023-07-053
OA